Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

RXRX

Market Cap$1.67B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Recursion Pharmaceuticals Inc - Ordinary Shares - Class ARecursion Pharmaceuticals Inc - Ordinary Shares - Class A-2.9--62%-0.1
$6.00

Target Price by Analysts

22.2% upsideRecursion Pharmaceuticals Target Price DetailsTarget Price

Share Statistics

Market cap$1.67 Billion
Enterprise Value$1.30 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.69
Beta0.98
Outstanding Shares402,771,972

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-2.93
PEG-2.41
Price to Sales-
Price to Book Ratio2.46
Enterprise Value to Revenue21.8
Enterprise Value to EBIT-2.29
Enterprise Value to Net Income-3
Total Debt to Enterprise0.1
Debt to Equity0.14

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Recursion Pharmaceuticals Inc

218 employees

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...